UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro Conference paper
Kawai, T., Forrester, S. J., Eguchi, K., Rizzo, V., Eguchi, S., Kwok, H. F., Murphy, G., Rossello, A.. Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro[C], Dallas, TX:American Heart Association, 2016, Suppl 1 ---.
Authors:  Kawai, T.;   Forrester, S. J.;  Eguchi, K.;  Rizzo, V.;  Eguchi, S.; et al.
Favorite |  | Submit date:2022/06/02
Angiotensin II  Signal Transduction  EGFR  
Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro Conference paper
Kawai, T., Forrester, S. J., Eguchi, K., Rizzo, V., Eguchi, S., Kwok, H. F., Murphy, G., Rossello, A.. Pharmacological Inhibition of ADAM17 by a Human-Cross Reactive Antibody and Selective Inhibitor JG26 Prevents Vascular Fibrosis Induced by Angiotensin II in vivo and in vitro[C], Dallas, TX:American Heart Association, 2016, Suppl 1 ---.
Authors:  Kawai, T.;   Forrester, S. J.;  Eguchi, K.;  Rizzo, V.;  Eguchi, S.; et al.
Favorite |  | Submit date:2022/06/02
Angiotensin II  Signal Transduction  EGFR